High-dose midazolam infusion for refractory status epilepticus

scientific article published on 20 December 2013

High-dose midazolam infusion for refractory status epilepticus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/WNL.0000000000000054
P932PMC publication ID3929199
P698PubMed publication ID24363133
P5875ResearchGate publication ID259449418

P50authorJ. Michael SchmidtQ43182649
Brandon ForemanQ57065601
Lawrence James HirschQ88149090
Belinda ShaoQ88309949
Jan ClaassenQ89261556
Stephan A. MayerQ111584599
P2093author name stringChristine Lesch
Hector Lantigua
Andres Fernandez
P2860cites workContinuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticusQ43747004
Refractory status epilepticus: frequency, risk factors, and impact on outcomeQ43885520
Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticusQ43998241
Refractory status epilepticus: a prospective observational studyQ44832149
Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolamQ46788719
Refractory status epilepticus: effect of treatment aggressiveness on prognosisQ46802749
Treatment of refractory generalized status epilepticus with continuous infusion of midazolamQ46877372
High-dose midazolam therapy for refractory status epilepticus in childrenQ48663156
Prolongation of midazolam half-life after sustained infusion for status epilepticusQ51408618
Intravenous midazolam for the treatment of refractory status epilepticusQ51693477
Status EpilepticusQ59664579
Functional and cognitive outcome in prolonged refractory status epilepticusQ82236451
Management of refractory status epilepticus in adults: still more questions than answersQ27028089
Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unitQ27477887
APACHE II: a severity of disease classification systemQ29547729
Refractory status epilepticusQ30436209
A randomized trial for the treatment of refractory status epilepticus.Q34024128
Assessment of outcome after severe brain damageQ34216702
Epilepsy emergencies: diagnosis and managementQ34250143
Propofol and midazolam in the treatment of refractory status epilepticus.Q34301397
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic reviewQ34570571
Detection of electrographic seizures with continuous EEG monitoring in critically ill patientsQ35782033
Guidelines for the evaluation and management of status epilepticusQ38004984
Emergency neurological life support: status epilepticusQ38041474
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectmidazolamQ423071
status epilepticusQ980709
P304page(s)359-365
P577publication date2013-12-20
P1433published inNeurologyQ1161692
P1476titleHigh-dose midazolam infusion for refractory status epilepticus
P478volume82